ZNF121 can influence the protein's function through various biochemical pathways. Forskolin, by activating adenylyl cyclase, increases the intracellular levels of cAMP, a secondary messenger that plays a pivotal role in cellular signaling. The elevated cAMP activates protein kinase A, which can phosphorylate a range of proteins, potentially including those interacting with ZNF121, leading to its activation. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP, thus sustaining PKA activity and enhancing the phosphorylation of proteins associated with ZNF121's function. Dibutyryl-cAMP, a synthetic analog of cAMP, bypasses cellular receptors and directly activates PKA, again promoting the activation of ZNF121 through phosphorylation cascades.
PMA and TPA, through their ability to activate protein kinase C, trigger a series of phosphorylation events that can lead to ZNF121 activation. This PKC-mediated signaling is part of a complex network where phosphorylation events regulate various aspects of cellular function. The calcium ionophores ionomycin and A23187 increase intracellular calcium levels, which can activate calcium-sensitive enzymes that are involved in pathways leading to ZNF121 activation. Thapsigargin also raises cytosolic calcium levels but does so by inhibiting calcium ATPase in the endoplasmic reticulum, leading to a similar activation of calcium-dependent signaling pathways. Additionally, anisomycin, through its role as a protein synthesis inhibitor, induces stress-activated protein kinase pathways, including the JNK pathway, which can lead to the activation of transcription factors and proteins interacting with ZNF121. Similarly, okadaic acid and calyculin A inhibit protein phosphatases, leading to increased phosphorylation and activation of proteins in pathways that include ZNF121. Finally, epinephrine, by binding to adrenergic receptors, enhances cAMP levels and thus PKA activity, which can subsequently lead to the phosphorylation and activation of proteins involved in ZNF121's regulatory mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP. This inhibition leads to increased cAMP levels, which in turn activates PKA. PKA can then phosphorylate proteins that are involved in the same signaling pathways as ZNF121, potentially leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is involved in multiple signaling pathways and can lead to the phosphorylation of proteins that interact with ZNF121, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular Ca2+ levels. Calcium activates calmodulin-dependent kinases and other calcium-sensitive enzymes that can interact with signaling pathways involving ZNF121, leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs) like JNK. Activation of JNK can lead to the activation of transcription factors that may interact with ZNF121 in its regulatory functions, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which leads to increased phosphorylation levels of many proteins. This can result in the activation of signaling cascades that include ZNF121, thereby activating it. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds adrenergic receptors, which can lead to increased cAMP through the activation of adenylyl cyclase. The increase in cAMP activates PKA, which may phosphorylate proteins within the ZNF121 signaling pathway, leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits protein phosphatases, leading to hyperphosphorylation of cellular proteins. This hyperphosphorylation could activate signaling pathways involving ZNF121, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which activates calcium-dependent signaling pathways that could include ZNF121, leading to its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate proteins related to ZNF121 signaling pathways, leading to the activation of ZNF121. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, similar to ionomycin, which increases intracellular calcium levels. This elevation in calcium can activate downstream signaling pathways that include ZNF121, leading to its activation. | ||||||